Delivery Order SPE2DB22D1017-SPE2DB24FG2FF
Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,820,356 units of the medication Dupixent 300 mg/2 ml pen. The contract has a firm fixed price of $72,774.35 and a completion date of September 17, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a $7,762.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,564,802,377 units of the medication Dupixent 300 mg/2 ml pen, with a completion date of June 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a...
- This is a $36,916.53 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the drug Dupixent 300 mg/2 ml pen, with a period of performance through April 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing pharmaceutical products...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,005.76, is for the delivery of 4,568,093,130 units of the prescription medication Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price, non-set-aside award with a performance period through May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This is a $10,618.06 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a large pharmaceutical distributor. The contract is for the supply of 4,565,295,219 units of the specialty medication Dupixent 300 mg/2 ml pens, with a period of performance through July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,837.84, is for the supply of 4,567,957,202 units of the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated....
- This is a $22,972.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
- This is a $56,588.57 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the medication Dupixent 300 mg/2 ml pen, with an ultimate completion date of August 15, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,093 units of the medication Dupixent 300 mg/2 ml pen, with a ceiling value of $44,600.53. The contract has an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,107.87 firm fixed price contract is for the delivery of Dupixent 300 mg/2 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...